openPR Logo
Press release

Long Term Growth in Deep Brain Stimulation Devices Market for Parkinson's Disease due to Rising Aging Population

01-12-2017 12:11 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Long Term Growth in Deep Brain Stimulation Devices Market

Since its inception about three decades ago, the fundamentals of software and hardware design for deep brain stimulation (DBS) have largely remained stagnant. However, improved understanding of disease progression pertaining to movement disorders combined with patient and clinician demands has led to the development of more advanced DBS technology. This will open growth avenues for deep brain stimulation and its allied realms, according to a research report by Transparency Market Research.

Obtain the Future Market Analysis of Deep Brain Stimulation Devices for Parkinson's Disease at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1435

While new electrode design for deep brain stimulation devices has enabled multi-target stimulation sans side-effects, new user-friendly software enables computational modelling and individualized directed programming.

Q. What is the usability of DBS devices for Parkinson’s disease?

A. The use of deep brain stimulation for Parkinson’s disease involves treating several disabling neurological symptoms such as tremor, slowed movement, rigidity, stiffness, and walking problems. While drug therapy is most commonly used for the treatment of Parkinson’s disease in initial stages, surgical intervention using DBS devices are used to control the symptoms of the disease in advanced stages.

DBS devices are effective, clinically proven and have received legal approvals for the advanced treatment of mild to severe form of Parkinson’s disease. The endorsements for the usability of these devices will benefit the growth of the deep brain stimulation devices market.

Q. How have technological advances benefitted the growth of the DBS devices market?

A. Tremendously. In a recent industry development, GlaxoSmithKline and Verily have joined hands to establish Galvani Bioelectronics – a joint venture for the development miniature implantable devices to modify nerve signals and also to collect information about the body’s neural networks. These miniature devices are designed to communicate with a hand-held receiver and leverage analytics and to treat patients more precisely.

This technology has been announced as bioelectronics medicine that works on the target area, unlike drugs that affect the entire body.

Q. What are the major factors propelling the growth of deep brain stimulation devices market?

A. The global deep brain stimulation devices market is driven by several factors. A rising geriatric population globally, an increasing incidence of Parkinson’s disease, and rising awareness about neurological movement disorders is fuelling the growth of this market. Moreover, favorable reimbursement policies are also contributing to the growing acceptance of these devices across the world.

Q. What are the factors holding back the growth of the deep brain stimulation devices market?

A. The risks associated with deep brain stimulation surgeries are the foremost factor holding back the market’s growth. Furthermore, the implementation of certain governmental policies such as the Affordable Care Act in the U.S. will hinder the growth of this market to some extent.

Read the Current Market Status of Deep Brain Stimulation Devices for Parkinson's Disease at: http://www.transparencymarketresearch.com/deep-brain-stimulator-market.html

The high-cost factor of deep brain stimulation surgical procedure is also restraining the market’s growth. However, the growing burden of Parkinson’s disease on healthcare systems of developed countries has necessitated original equipment manufacturers (OEMs) to develop cost-effective devices for the treatment of Parkinson’s disease.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Long Term Growth in Deep Brain Stimulation Devices Market for Parkinson's Disease due to Rising Aging Population here

News-ID: 411347 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Parkinson

QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency. The firm recognised that to continue delivering high quality services to its clients it needed to provide
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global
PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services a …
The Parkinson Research Foundation is pleased to announce that Marilyn Tait has joined the foundation as the Director of Patient Programs, Services and Advocacy. Tait, is a graduate of Thomas Jefferson University School of Nursing in Philadelphia, Pennsylvania. Tait has forty years experience in healthcare marketing and program development. After specializing in oncology for 30 years, Tait embarked on her new career at a time in her life when
PARKINSON RESEARCH FOUNDATION’S (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU …
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field. After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRF’s focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease. The Foundation’s educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affected
Parkinson`s Disease:New Hope Educational Conference
PARKINSON’S DISEASE: NEW HOPE EDUCATIONAL CONFERENCE Become knowledgeable about the advancements in surgery The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinson’s conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinson’s disease and movement disorders. He has an extensive background and